Simone Fulda

65.5k total citations · 5 hit papers
395 papers, 27.4k citations indexed

About

Simone Fulda is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Simone Fulda has authored 395 papers receiving a total of 27.4k indexed citations (citations by other indexed papers that have themselves been cited), including 343 papers in Molecular Biology, 92 papers in Oncology and 83 papers in Immunology. Recurrent topics in Simone Fulda's work include Cell death mechanisms and regulation (212 papers), Autophagy in Disease and Therapy (48 papers) and Cancer-related Molecular Pathways (47 papers). Simone Fulda is often cited by papers focused on Cell death mechanisms and regulation (212 papers), Autophagy in Disease and Therapy (48 papers) and Cancer-related Molecular Pathways (47 papers). Simone Fulda collaborates with scholars based in Germany, United States and United Kingdom. Simone Fulda's co-authors include Klaus‐Michael Debatin, Guido Kroemer, Lorenzo Galluzzi, Claudia Friesen, Domagoj Vucic, Éric Meyer, Adrienne M. Gorman, Afshin Samali, Osamu Hori and Donat Kögel and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Simone Fulda

392 papers receiving 27.0k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy

2006 1.9k citations Simone Fulda, Klaus‐Michael Debatin profile →
Targeting mitochondria for cancer therapy

2010 1.4k citations Simone Fulda et al. profile →
Cellular Stress Responses: Cell Survival and Cell Death

2010 1.1k citations Simone Fulda et al. profile →
Targeting IAP proteins for therapeutic intervention in cancer

2012 639 citations Simone Fulda et al. profile →
Smac agonists sensitize for Apo2L/TRAIL- or anticancer drug-induced apoptosis and induce regression of malignant glioma in vivo

2002 605 citations Simone Fulda, Klaus‐Michael Debatin et al. profile →

Peers

Countries citing papers authored by Simone Fulda

Since Specialization

Citations

This map shows the geographic impact of Simone Fulda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simone Fulda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simone Fulda more than expected).

Fields of papers citing papers by Simone Fulda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simone Fulda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simone Fulda. The network helps show where Simone Fulda may publish in the future.

Co-authorship network of co-authors of Simone Fulda

This figure shows the co-authorship network connecting the top 25 collaborators of Simone Fulda. A scholar is included among the top collaborators of Simone Fulda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simone Fulda. Simone Fulda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mathematical modeling of the molecular switch of TNFR1-mediated signaling pathways applying Petri net formalism and in silico knockout analysis 2022 ·PLoS Computational Biology ·(unknown), Jörg Ackermann, (unknown), Ivan Đikić, Simone Fulda, Ina Koch	5
2	Genetic deletion of Nox4 enhances cancerogen-induced formation of solid tumors 2021 ·Proceedings of the National Academy of Sciences ·Valeska Helfinger, (unknown), (unknown), (unknown), Tobias Schmid, Flávia Rezende, Juliana Heidler, Ilka Wittig, Heinfried H. Radeke, Viola Marschall, Karen E. Anderson, Ajay M. Shah, Simone Fulda, Bernhard Brüne, Ralf P. Brandes, Katrin Schröder	25
3	A direct comparison of selective BH3-mimetics reveals BCL-XL, BCL-2 and MCL-1 as promising therapeutic targets in neuroblastoma 2020 ·British Journal of Cancer ·(unknown), (unknown), Meike Vogler, Simone Fulda	25
4	NRAS -Mutated Rhabdomyosarcoma Cells Are Vulnerable to Mitochondrial Apoptosis Induced by Coinhibition of MEK and PI3K α 2018 ·Cancer Research ·(unknown), Manuela Hugle, Meike Vogler, Simone Fulda	14
5	Interference with the HSF1/HSP70/BAG3 Pathway Primes Glioma Cells to Matrix Detachment and BH3 Mimetic–Induced Apoptosis 2016 ·Molecular Cancer Therapeutics ·(unknown), Benedikt Linder, Stephanie Hehlgans, Iris Mildenberger, Michael C. Burger, Simone Fulda, Jörg Steinbach, Florian Geßler, Franz Rödel, Michel Mittelbronn, Donat Kögel	64
6	PARP Inhibitors Sensitize Ewing Sarcoma Cells to Temozolomide-Induced Apoptosis via the Mitochondrial Pathway 2015 ·Molecular Cancer Therapeutics ·Florian Engert, Cornelius Schneider, (unknown), (unknown), Simone Fulda	47
7	APG350 Induces Superior Clustering of TRAIL Receptors and Shows Therapeutic Antitumor Efficacy Independent of Cross-Linking via Fcγ Receptors 2013 ·Molecular Cancer Therapeutics ·Christian Gieffers, Michael Kluge, Christian J. Merz, Jaromir Sykora, Meinolf Thiemann, (unknown), Carmen Fischer, (unknown), Behnaz Ahangarian Abhari, Peter Hohenberger, Simone Fulda, Harald Fricke, Oliver Hill	94
8	Differential Induction of Apoptosis and Senescence by the DNA Methyltransferase Inhibitors 5-Azacytidine and 5-Aza-2′-Deoxycytidine in Solid Tumor Cells 2013 ·Molecular Cancer Therapeutics ·Sascha Venturelli, Alexander Berger, Timo Weiland, Frank Eßmann, Michaela Waibel, Tina Nuebling, Sabine Häcker, Martin Schenk, Klaus Schulze‐Osthoff, Helmut R. Salih, Simone Fulda, Bence Sipos, Ricky W. Johnstone, Ulrich M. Lauer, Michael Bitzer	86
9	NF-κB Is Required for Smac Mimetic-Mediated Sensitization of Glioblastoma Cells for γ-Irradiation–Induced Apoptosis 2011 ·Molecular Cancer Therapeutics ·(unknown), (unknown), Viola Marschall, Sabine Karl, Silvia Cristofanon, Liane Wagner, Sri HariKrishna Vellanki, Stephanie Hehlgans, Franz Rödel, Klaus‐Michael Debatin, Albert C. Ludolph, Simone Fulda	67
10	Bortezomib Primes Neuroblastoma Cells for TRAIL-Induced Apoptosis by Linking the Death Receptor to the Mitochondrial Pathway 2011 ·Clinical Cancer Research ·(unknown), Roland Kappler, Dietrich von Schweinitz, Klaus‐Michael Debatin, Simone Fulda	51
11	Targeting Aberrant PI3K/Akt Activation by PI103 Restores Sensitivity to TRAIL-Induced Apoptosis in Neuroblastoma 2011 ·Clinical Cancer Research ·Daniela Opel, (unknown), (unknown), (unknown), Klaus‐Michael Debatin, Simone Fulda	55
12	TRAIL-Induced Apoptosis Is Preferentially Mediated via TRAIL Receptor 1 in Pancreatic Carcinoma Cells and Profoundly Enhanced by XIAP Inhibitors 2010 ·Clinical Cancer Research ·Dominic Stadel, Andrea Mohr, (unknown), Marion MacFarlane, Shaoxia Zhou, Robin Humphreys, Max G. Bachem, (unknown), Peter Möller, Ralf M. Zwacka, Klaus‐Michael Debatin, Simone Fulda	61
13	CD95 co-stimulation blocks activation of naive T cells by inhibiting T cell receptor signaling 2009 ·The Journal of Experimental Medicine ·Gudrun Strauß, Jonathan A. Lindquist, Nathalie J. Arhel, Edward Felder, Sabine Karl, Tobias L. Haas, Simone Fulda, Henning Walczak, Frank Kirchhoff, Klaus‐Michael Debatin	28
14	Small Molecule XIAP Inhibitors Enhance TRAIL-Induced Apoptosis and Antitumor Activity in Preclinical Models of Pancreatic Carcinoma 2009 ·Cancer Research ·Meike Vogler, Henning Walczak, Dominic Stadel, Tobias L. Haas, Felicitas Genze, (unknown), Umesh Bhanot, Cornelia Hasel, Peter Möller, Jürgen E. Gschwend, Thomas Simmet, Klaus‐Michael Debatin, Simone Fulda	121
15	A Novel Paradigm to Trigger Apoptosis in Chronic Lymphocytic Leukemia 2009 ·Cancer Research ·(unknown), Thorsten Zenz, Andrea Schnaiter, Daniel Mertens, Dirk Winkler, Hartmut Döhner, Klaus‐Michael Debatin, Stephan Stilgenbauer, Simone Fulda	45
16	Targeting XIAP Bypasses Bcl-2–Mediated Resistance to TRAIL and Cooperates with TRAIL to Suppress Pancreatic Cancer Growth In vitro and In vivo 2008 ·Cancer Research ·Meike Vogler, Henning Walczak, Dominic Stadel, Tobias L. Haas, Felicitas Genze, (unknown), Jürgen E. Gschwend, Thomas Simmet, Klaus‐Michael Debatin, Simone Fulda	135
17	Phosphatidylinositol 3-Kinase Inhibition Broadly Sensitizes Glioblastoma Cells to Death Receptor– and Drug-Induced Apoptosis 2008 ·Cancer Research ·Daniela Opel, Mike‐Andrew Westhoff, (unknown), Veit Braun, Klaus‐Michael Debatin, Simone Fulda	123
18	Activation of Akt Predicts Poor Outcome in Neuroblastoma 2007 ·Cancer Research ·Daniela Opel, Christopher Poremba, Thorsten Simon, Klaus‐Michael Debatin, Simone Fulda	198
19	Loss of Caspase-8 Expression Does Not Correlate with MYCN Amplification, Aggressive Disease, or Prognosis in Neuroblastoma 2006 ·Cancer Research ·Simone Fulda, Christopher Poremba, Bernd Berwanger, Sabine Häcker, Martin Eilers, Holger Christiansen, Barbara Hero, Klaus‐Michael Debatin	33
20	Sensitization for γ-Irradiation–Induced Apoptosis by Second Mitochondria-Derived Activator of Caspase 2005 ·Cancer Research ·(unknown), Meike Vogler, Mike‐Andrew Westhoff, Hubert Kasperczyk, Klaus‐Michael Debatin, Simone Fulda	61

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact